RELAPSING REMITTING MULTIPLE SCLEROSIS

This study monitored patients with relapsing or progressive multiple sclerosis (MS) who were taking Kesimpta injections for two years. The main goal was to track side effects and see how well the drug worked at preventing relapses and slowing disability. Researchers followed 367 …

This study tested whether adding an oral medication called PIPE-307 to existing multiple sclerosis treatments could help control the disease. About 182 adults with relapsing-remitting MS took either one of two doses of PIPE-307 or a placebo pill for about 30 weeks. Researchers me…

This study tested whether virtual reality (VR) tasks, like navigating a virtual supermarket or using a driving simulator, are better than standard paper-and-pencil tests at detecting the thinking and planning problems that often occur with multiple sclerosis (MS). Researchers com…

This study looked back at how the first wave of the COVID-19 pandemic affected the care of people with multiple sclerosis (MS) when they had a relapse. Researchers compared 51 patients who had a relapse in spring 2020 to a similar group from spring 2019. The goal was to see if th…

This study aimed to understand if people with unusual forms of multiple sclerosis (MS) have a different or more severe disease process. Researchers compared blood levels of specific proteins (neurofilament light chain and GFAP) in 15 patients with atypical MS to 30 patients with …